Literature DB >> 19280666

COX-2 polymorphisms and the risk for head and neck cancer in white patients.

Wilbert H M Peters1, Martin Lacko, Rene H M Te Morsche, Adri C Voogd, Michael B Oude Ophuis, Johannes J Manni.   

Abstract

BACKGROUND: Cyclooxygenase-2 (COX-2) is an enzyme involved in the synthesis of prostaglandins and thromboxanes, which are regulators of processes such as inflammation, cell proliferation, and angiogenesis, all relevant for cancer development. We investigated whether functional genetic polymorphisms in COX-2 may have a risk-modifying effect on head and neck carcinogenesis.
METHODS: Blood from 431 white patients with oral, pharyngeal, or laryngeal carcinoma and 438 white healthy controls was investigated for the presence of 2 functional promoter region polymorphisms (-1195A-->G and -765G-->C) in COX-2.
RESULTS: Logistic regression analysis did not show differences in COX-2 genotype distributions between patients and controls. Also no differences were found when stratified according to tumor localization, sex, or tobacco consumption.
CONCLUSION: In contrast to earlier reports on the role of these COX-2 polymorphisms in mediating susceptibility to squamous esophageal carcinoma in a Chinese population, we could not demonstrate a risk-modifying effect in head and neck carcinogenesis in whites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280666     DOI: 10.1002/hed.21058

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  15 in total

1.  Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men.

Authors:  Satoru Sugie; Hiromasa Tsukino; Shoichiro Mukai; Takahiro Akioka; Norihiko Shibata; Masafumi Nagano; Toshiyuki Kamoto
Journal:  Tumour Biol       Date:  2013-11-08

2.  Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.

Authors:  Elizabeth Van Tubergen; Robert Vander Broek; Julia Lee; Gregory Wolf; Thomas Carey; Carol Bradford; Mark Prince; Keith L Kirkwood; Nisha J D'Silva
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

3.  -765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies.

Authors:  Wei Zhu; Bing-bing Wei; Xia Shan; Ping Liu
Journal:  Mol Biol Rep       Date:  2009-08-09       Impact factor: 2.316

4.  Association of the -14C/G MET and the -765G/C COX-2 gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population.

Authors:  Przemyslaw Sitarek; Hanna Zielinska-Blizniewska; Lukasz Dziki; Jaroslaw Milonski; Karolina Przybylowska; Bartosz Mucha; Jurek Olszewski; Ireneusz Majsterek
Journal:  DNA Cell Biol       Date:  2012-03-14       Impact factor: 3.311

5.  Cox-2 and IL-10 polymorphisms and association with squamous cell carcinoma of the head and neck in a Korean sample.

Authors:  Seung Won Jeong; Kyung Tae; Seung Hwan Lee; Kyung Rae Kim; Chul Won Park; Byung Lae Park; Hyoung Doo Shin
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

6.  The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease.

Authors:  Hilbert S de Vries; Rene H M te Morsche; Martijn G H van Oijen; Iris D Nagtegaal; Wilbert H M Peters; Dirk J de Jong
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

7.  Cyclooxygenase-2 polymorphisms and the risk of gastric cancer in various degrees of relationship in the Chinese Han population.

Authors:  Yuchun Li; Liping Dai; Jianzhong Zhang; Peng Wang; Yurong Chai; Hua Ye; Jianying Zhang; Kaijuan Wang
Journal:  Oncol Lett       Date:  2011-09-20       Impact factor: 2.967

8.  Cyclooxygenase-2 -1195G>A (rs689466) polymorphism and cancer susceptibility: an updated meta-analysis involving 50,672 subjects.

Authors:  Yafeng Wang; Heping Jiang; Tianyun Liu; Weifeng Tang; Zhiqiang Ma
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

10.  Cyclooxygenase-2-1195G>A Polymorphism and Head and Neck Squamous Cell Carcinoma Susceptibility: A Meta-Analysis of 1564 Cases and 2346 Controls.

Authors:  Dong-Lai Deng; Ling-Yun Xia; Bing-Yang He; Jing-Mei Guo; Cui Huang; Xian-Tao Zeng
Journal:  Med Sci Monit       Date:  2015-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.